JP2002523514A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002523514A5 JP2002523514A5 JP2000567539A JP2000567539A JP2002523514A5 JP 2002523514 A5 JP2002523514 A5 JP 2002523514A5 JP 2000567539 A JP2000567539 A JP 2000567539A JP 2000567539 A JP2000567539 A JP 2000567539A JP 2002523514 A5 JP2002523514 A5 JP 2002523514A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9831398P | 1998-08-27 | 1998-08-27 | |
| US60/098,313 | 1998-08-27 | ||
| US12974399P | 1999-04-16 | 1999-04-16 | |
| US60/129,743 | 1999-04-16 | ||
| US14446199P | 1999-07-19 | 1999-07-19 | |
| US60/144,461 | 1999-07-19 | ||
| PCT/US1999/019838 WO2000012517A1 (en) | 1998-08-27 | 1999-08-27 | Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009035788A Division JP2009143955A (ja) | 1998-08-27 | 2009-02-18 | アレンドロネートナトリウムの新規水和物型、その製造方法、及びその医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002523514A JP2002523514A (ja) | 2002-07-30 |
| JP2002523514A5 true JP2002523514A5 (enExample) | 2005-12-22 |
Family
ID=27378576
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000567539A Withdrawn JP2002523514A (ja) | 1998-08-27 | 1999-08-27 | アレンドロネートナトリウムの新規水和物型、その製造方法、及びその医薬組成物 |
| JP2009035788A Pending JP2009143955A (ja) | 1998-08-27 | 2009-02-18 | アレンドロネートナトリウムの新規水和物型、その製造方法、及びその医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009035788A Pending JP2009143955A (ja) | 1998-08-27 | 2009-02-18 | アレンドロネートナトリウムの新規水和物型、その製造方法、及びその医薬組成物 |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US6281381B1 (enExample) |
| EP (1) | EP1107974B1 (enExample) |
| JP (2) | JP2002523514A (enExample) |
| KR (2) | KR20070034132A (enExample) |
| AT (1) | ATE334993T1 (enExample) |
| AU (1) | AU5698899A (enExample) |
| BG (1) | BG65329B1 (enExample) |
| BR (1) | BR9913472A (enExample) |
| CA (1) | CA2341459A1 (enExample) |
| CZ (1) | CZ2001629A3 (enExample) |
| DE (1) | DE69932620T2 (enExample) |
| DK (1) | DK1107974T3 (enExample) |
| EA (1) | EA002739B1 (enExample) |
| EE (1) | EE04552B1 (enExample) |
| ES (1) | ES2270613T3 (enExample) |
| HR (1) | HRP20010129A2 (enExample) |
| HU (1) | HUP0203078A3 (enExample) |
| IL (1) | IL141423A (enExample) |
| IS (1) | IS5864A (enExample) |
| LT (1) | LT4888B (enExample) |
| LV (1) | LV12720B (enExample) |
| NO (1) | NO20010957L (enExample) |
| NZ (1) | NZ510682A (enExample) |
| PL (1) | PL346347A1 (enExample) |
| PT (1) | PT1107974E (enExample) |
| RO (1) | RO122854B1 (enExample) |
| SI (1) | SI20581B (enExample) |
| SK (1) | SK2482001A3 (enExample) |
| WO (1) | WO2000012517A1 (enExample) |
| YU (1) | YU14701A (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE455121T1 (de) * | 2001-07-16 | 2010-01-15 | Univ Paris 13 | Herstellungsverfahren von derivate von bisphosphonaten |
| GB2383042A (en) | 2001-10-18 | 2003-06-18 | Cipla Ltd | Amorphous alendronate sodium |
| US20040052843A1 (en) * | 2001-12-24 | 2004-03-18 | Lerner E. Itzhak | Controlled release dosage forms |
| EP2172192A1 (en) * | 2001-12-24 | 2010-04-07 | Teva Pharmaceutical Industries Ltd. | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder of granular material, and process and tooling for producing it |
| ITMI20020146A1 (it) * | 2002-01-29 | 2003-07-29 | Lyogen Ltd | Alendronato monosodico amorfo e processo per la sua preparazione |
| US20030195171A1 (en) * | 2002-04-05 | 2003-10-16 | Daifotis Anastasia G. | Method for inhibiting bone resorption with an alendronate and vitamin D formulation |
| US20080249068A1 (en) * | 2002-09-05 | 2008-10-09 | Deluca Hector F | Method of Extending the Dose Range of Vitamin D Compounds |
| US20050113343A1 (en) * | 2003-10-14 | 2005-05-26 | Pliva - Research And Development Ltd. | Solid-state form of alendronate sodium and preparation thereof |
| US20050181043A1 (en) * | 2004-02-12 | 2005-08-18 | Indranil Nandi | Alendronate salt tablet compositions |
| US20050261250A1 (en) * | 2004-05-19 | 2005-11-24 | Merck & Co., Inc., | Compositions and methods for inhibiting bone resorption |
| AU2005247299B2 (en) | 2004-05-24 | 2008-05-15 | Allergan Pharmaceuticals International Limited | Enteric solid oral dosage form of bisphosphonate containing a chelating agent |
| CZ296937B6 (cs) * | 2004-09-02 | 2006-07-12 | Zentiva, A. S | Trisodná sul kyseliny 4-amino-1-hydroxybutyliden-1,1-bisfosfonové |
| WO2006050122A1 (en) * | 2004-10-29 | 2006-05-11 | Sandoz Ag | Processes for preparing glatiramer |
| US20060134190A1 (en) * | 2004-12-16 | 2006-06-22 | Banner Pharmacaps Inc. | Formulations of bisphosphonate drugs with improved bioavailability |
| CZ297262B6 (cs) * | 2004-12-28 | 2006-10-11 | Zentiva, A. S. | Trisodná sul kyseliny 4-amino-1-hydroxybutyliden-1,1-bisfosfonové |
| US8003820B2 (en) * | 2005-10-20 | 2011-08-23 | Dr. Reddy's Laboratories Limited | Process for preparing bisphosphonic acids |
| AR058168A1 (es) * | 2005-11-07 | 2008-01-23 | Merck & Co Inc | Sintesis del alendronato de sodio trihidratado |
| ES2567051T3 (es) * | 2006-10-27 | 2016-04-19 | Signal Pharmaceuticals, Llc | Formas sólidas que comprenden 4-[9-(3S)-(tetrahidro-furan-3-il)-8-(2,4,6-trifluoro-fenilamino)-9H-purin-2-ilamino]-trans-ciclohexan-1-ol, sus composiciones y sus usos |
| ES2392890T3 (es) * | 2006-11-22 | 2012-12-14 | Eisai R&D Management Co., Ltd. | Sal sódica de un compuesto disacarídico, procedimiento para la producción de la misma y uso de la misma |
| US20090118238A1 (en) * | 2007-09-17 | 2009-05-07 | Protia, Llc | Deuterium-enriched alendronate |
| US20090076144A1 (en) * | 2007-09-17 | 2009-03-19 | Protia, Llc | Deuterium-enriched bazedoxifene |
| US20090170815A1 (en) * | 2007-12-28 | 2009-07-02 | Roxane Laboratories Incorporated. | Alendronate oral liquid formulations |
| CN102040644B (zh) * | 2009-11-03 | 2014-05-14 | 刘力 | 丹参酮衍生物及其制备和用途 |
| SG10202012791TA (en) | 2013-11-15 | 2021-01-28 | Akebia Therapeutics Inc | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3016289A1 (de) | 1980-04-28 | 1981-10-29 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren |
| IT1201087B (it) * | 1982-04-15 | 1989-01-27 | Gentili Ist Spa | Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche |
| US4639338A (en) | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
| DE3434667A1 (de) * | 1984-09-21 | 1986-04-03 | Henkel KGaA, 4000 Düsseldorf | 4-dimethylamino-1-hydroxybutan-1,1-diphosphonsaeure, deren wasserloesliche salze, verfahren zu ihrer herstellung sowie ihre verwendung |
| IT1196315B (it) | 1984-10-29 | 1988-11-16 | Gentili Ist Spa | Procedimento per la preparazione di acidi difosfonici |
| US4711800A (en) * | 1985-06-06 | 1987-12-08 | Divincenzo Maureen | Needlecraft with metallic substrate |
| US4922007A (en) | 1989-06-09 | 1990-05-01 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
| US5019651A (en) | 1990-06-20 | 1991-05-28 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof |
| US5039819A (en) | 1990-09-18 | 1991-08-13 | Merck & Co., Inc. | Diphosphonate intermediate for preparing an antihypercalcemic agent |
| US5159108A (en) * | 1990-09-18 | 1992-10-27 | Merck & Co., Inc. | Process for preparing an antihypercalcemic agent |
| EP0837863A4 (en) * | 1995-06-06 | 1999-06-16 | Merck & Co Inc | DISODIUM ALENDRONATE PREPARATIONS |
| DK0833643T3 (da) * | 1995-06-06 | 2005-05-30 | Merck & Co Inc | Formuleringer af vandfrit mononatriumsalt af alendronat og deres anvendelse til behandling af knoglesygdomme |
-
1999
- 1999-08-27 EP EP99944004A patent/EP1107974B1/en not_active Expired - Lifetime
- 1999-08-27 CA CA002341459A patent/CA2341459A1/en not_active Abandoned
- 1999-08-27 HU HU0203078A patent/HUP0203078A3/hu unknown
- 1999-08-27 NZ NZ510682A patent/NZ510682A/en not_active IP Right Cessation
- 1999-08-27 CZ CZ2001629A patent/CZ2001629A3/cs unknown
- 1999-08-27 EA EA200100184A patent/EA002739B1/ru not_active IP Right Cessation
- 1999-08-27 DE DE69932620T patent/DE69932620T2/de not_active Expired - Fee Related
- 1999-08-27 AU AU56988/99A patent/AU5698899A/en not_active Abandoned
- 1999-08-27 DK DK99944004T patent/DK1107974T3/da active
- 1999-08-27 US US09/384,145 patent/US6281381B1/en not_active Expired - Fee Related
- 1999-08-27 KR KR1020077004456A patent/KR20070034132A/ko not_active Ceased
- 1999-08-27 AT AT99944004T patent/ATE334993T1/de not_active IP Right Cessation
- 1999-08-27 JP JP2000567539A patent/JP2002523514A/ja not_active Withdrawn
- 1999-08-27 HR HR20010129A patent/HRP20010129A2/hr not_active Application Discontinuation
- 1999-08-27 KR KR1020017002535A patent/KR20010079701A/ko not_active Ceased
- 1999-08-27 BR BR9913472-1A patent/BR9913472A/pt not_active Application Discontinuation
- 1999-08-27 YU YU14701A patent/YU14701A/sh unknown
- 1999-08-27 PL PL99346347A patent/PL346347A1/xx not_active Application Discontinuation
- 1999-08-27 WO PCT/US1999/019838 patent/WO2000012517A1/en not_active Ceased
- 1999-08-27 IL IL14142399A patent/IL141423A/xx not_active IP Right Cessation
- 1999-08-27 EE EEP200100126A patent/EE04552B1/xx not_active IP Right Cessation
- 1999-08-27 PT PT99944004T patent/PT1107974E/pt unknown
- 1999-08-27 RO ROA200100219A patent/RO122854B1/ro unknown
- 1999-08-27 SK SK248-2001A patent/SK2482001A3/sk unknown
- 1999-08-27 SI SI9920070A patent/SI20581B/sl not_active IP Right Cessation
- 1999-08-27 ES ES99944004T patent/ES2270613T3/es not_active Expired - Lifetime
-
2001
- 2001-02-26 NO NO20010957A patent/NO20010957L/no not_active Application Discontinuation
- 2001-02-26 BG BG105292A patent/BG65329B1/bg unknown
- 2001-02-26 IS IS5864A patent/IS5864A/is unknown
- 2001-02-26 LT LT2001016A patent/LT4888B/lt not_active IP Right Cessation
- 2001-04-05 LV LVP-01-26A patent/LV12720B/en unknown
- 2001-07-03 US US09/898,756 patent/US6696601B2/en not_active Expired - Fee Related
-
2009
- 2009-02-18 JP JP2009035788A patent/JP2009143955A/ja active Pending